238 related articles for article (PubMed ID: 15582082)
41. Characterization of ocular and metastatic uveal melanoma in an animal model.
Blanco PL; Marshall JC; Antecka E; Callejo SA; Souza Filho JP; Saraiva V; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4376-82. PubMed ID: 16303923
[TBL] [Abstract][Full Text] [Related]
42. Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada.
Xing L; Dorrepaal SJ; Gale J
Can J Ophthalmol; 2014 Jun; 49(3):261-6. PubMed ID: 24862772
[TBL] [Abstract][Full Text] [Related]
43. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
Rashid AB; Grossniklaus HE
Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
[TBL] [Abstract][Full Text] [Related]
44. Physician participation in a randomized clinical trial for ocular melanoma.
Taylor KM
Ann Ophthalmol; 1992 Sep; 24(9):337-44. PubMed ID: 1471822
[TBL] [Abstract][Full Text] [Related]
45. Modeling the behavior of uveal melanoma in the liver.
Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
[TBL] [Abstract][Full Text] [Related]
46. The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group.
Al-Jamal RT; Cassoux N; Desjardins L; Damato B; Konstantinidis L; Coupland SE; Heimann H; Petrovic A; Zografos L; Schalenbourg A; Velazquez-Martin JP; Krema H; Bogdali A; Markiewicz A; Romanowska-Dixon B; Metz CH; Biewald E; Bornfeld N; Kiratli H; Bronkhorst IH; Jager MJ; Marinkovic M; Fili M; Seregard S; Frenkel S; Pe'er J; Salvi SM; Rennie IG; Rospond-Kubiak I; Kociecki J; Kiilgaard JF; Heegaard S; Cohen VM; Sagoo MS; Amiryan A; Saakyan S; Eide N; Krohn J; Midena E; Parrozzani R; Grange JD; Kilic E; Blasi MA; Saornil MA; Kivelä TT
Ophthalmology; 2016 Apr; 123(4):898-907. PubMed ID: 26854035
[TBL] [Abstract][Full Text] [Related]
47. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
[TBL] [Abstract][Full Text] [Related]
48. Are too many imaging tests being performed in women with an adnexal mass?
Kupets R; Fernandes K; Miroshnichenko G; Paszat L
J Obstet Gynaecol Can; 2013 Mar; 35(3):246-251. PubMed ID: 23470112
[TBL] [Abstract][Full Text] [Related]
49. Locoregional management of hepatic metastasis from primary uveal melanoma.
Sato T
Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
[TBL] [Abstract][Full Text] [Related]
50. Rural physicians' perspectives on cervical and breast cancer screening: a gender-based analysis.
Ahmad F; Stewart DE; Cameron JI; Hyman I
J Womens Health Gend Based Med; 2001 Mar; 10(2):201-8. PubMed ID: 11268303
[TBL] [Abstract][Full Text] [Related]
51. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23.
Diener-West M; Reynolds SM; Agugliaro DJ; Caldwell R; Cumming K; Earle JD; Green DL; Hawkins BS; Hayman J; Jaiyesimi I; Kirkwood JM; Koh WJ; Robertson DM; Shaw JM; Thoma J;
J Clin Oncol; 2004 Jun; 22(12):2438-44. PubMed ID: 15197206
[TBL] [Abstract][Full Text] [Related]
52. An evaluation of clinical follow-up in women with early stage breast cancer among physician members of the American Society of Clinical Oncology.
Simon MS; Hoff M; Hussein M; Martino S; Walt A
Breast Cancer Res Treat; 1993 Sep; 27(3):211-9. PubMed ID: 8312579
[TBL] [Abstract][Full Text] [Related]
53. Current clinical practice in cytoreductive surgery for advanced ovarian cancer: a European survey.
Cibula D; Verheijen R; Lopes A; Dusek L;
Int J Gynecol Cancer; 2011 Oct; 21(7):1219-24. PubMed ID: 21892096
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis and treatment of uveal melanoma.
Shields JA; Shields CL; De Potter P; Singh AD
Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
[TBL] [Abstract][Full Text] [Related]
55. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
[TBL] [Abstract][Full Text] [Related]
56. Suspected vitreous seeding of uveal melanoma: relevance of diagnostic vitrectomy.
Metz CH; Bornfeld N; Metz KA; Gök M
Br J Ophthalmol; 2016 May; 100(5):660-4. PubMed ID: 26359338
[TBL] [Abstract][Full Text] [Related]
57. Geographic variation in posttreatment surveillance intensity for patients with cutaneous melanoma.
Margenthaler JA; Meier JD; Virgo KS; Johnson DY; Goshima K; Chan D; Handler BS; Johnson FE
Am J Surg; 2003 Aug; 186(2):194-200. PubMed ID: 12885617
[TBL] [Abstract][Full Text] [Related]
58. Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma.
Kaiserman I; Anteby I; Chowers I; Blumenthal EZ; Kliers I; Pe'er J
Br J Ophthalmol; 2004 Jul; 88(7):892-5. PubMed ID: 15205232
[TBL] [Abstract][Full Text] [Related]
59. Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians.
Provost N; Marghoob AA; Kopf AW; DeDavid M; Wasti Q; Bart RS
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):711-20. PubMed ID: 9146532
[TBL] [Abstract][Full Text] [Related]
60. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
